Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valtris Specialty Chemicals is a leading global manufacturer of specialty chemical additives and precursors, serving diverse markets including medical devices, pharmaceutical packaging, and consumer goods. The company specializes in the production of polymer additives such as stabilizers, plasticizers, and antimicrobial agents that enhance the performance and durability of plastics and coatings. Within the healthcare sector, Valtris provides high-purity, non-phthalate plasticizers for medical-grade tubing and specialized biocides used to prevent microbial growth in sensitive clinical environments. Headquartered in Independence, Ohio, the company operates a robust global manufacturing footprint across North America, Europe, and Asia. Valtris was formed from the divestiture of Ferro Corporation’s polymer additives business and is currently a portfolio company of SK Capital Partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valtris Specialty Chemicals.